Diagnostic Value of Combining Tumor and Inflammatory Markers in Lung Cancer

Mostrar otras versiones (1)

BACKGROUND: Despite major advances in lung cancer treatment, early detection remains the most promising way of improving outcomes. To detect lung cancer in earlier stages, many serum biomarkers have been tested. Unfortunately, no single biomarker can reliably detect lung cancer. We combined a set of...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoon, Ho Il, Kwon, Oh-Ran, Kang, Kyung Nam, Shin, Yong Sung, Shin, Ho Sang, Yeon, Eun Hee, Kwon, Keon Young, Hwang, Ilseon, Jeon, Yoon Kyung, Kim, Yongdai, Kim, Chul Woo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Cancer Prevention 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5051593/
https://www.ncbi.nlm.nih.gov/pubmed/27722145
http://dx.doi.org/10.15430/JCP.2016.21.3.187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5051593/
https://www.ncbi.nlm.nih.gov/pubmed/27722145
http://dx.doi.org/10.15430/JCP.2016.21.3.187

Ejemplares similares